Advancing clinical trial accessibility: A novel software breakthrough in enrollment efficiency

Clinical trials are vital for advancing treatment options to the clinic but often face challenges in patient enrollment. For example, the Cancer Research Institute estimates that only 3% to 6% of eligible cancer patients in the U.S. participate in trials. Patients may be dissuaded from clinical trial participation by accessibility issues, such as distance and transportation costs.